Ascept
  • Home
  • About ASCEPT
    • What is Pharmacology/Toxicology?
    • Clinical Pharmacology
    • History
    • Honour Roll/Life Members Page
  • Join ASCEPT
  • Members
    • Renew
    • Awards and Prizes
    • Travel Grants
    • Member Spotlight
    • Benefits
      • Mentoring Program
    • Special Interest Groups
    • Mentoring Program
  • Annual Scientific Meeting 2012
    • Registration
    • Abstracts
    • Oral & Poster Instructions
    • Workshops
    • Awards and Prizes
    • Travel Grants
    • Social Program
    • Sponsors & Exhibitors
    • Contact Us
  • NZ Section
  • Events
  • Past Annual Scientific Meetings
    • 2010
      • Proceedings
      • Speakers
      • Accommodation
      • Program
      • Venue
      • Sponsors & Exhibitors
    • 2011
      • Welcome
      • Program
      • Speakers
      • Workshops
      • Special Interest Groups
      • Awards and Prizes
      • Travel Grants
      • Social Program
      • Sponsors & Exhibitors
  • News & Media
    • E-News
    • Media
  • Special Interest Groups
    • Clinical Pharmacology
    • Drug Discovery
    • Education
      • Carrick Project
    • Pharmacogenomics
    • Gastrointestinal Urogenital Pharmacology
    • Toxicology
    • Cardiovascular
    • Drug Disposition and Response
  • ASCEPT Sponsors
  • ASCEPT FORUMS
  • SEAWP-RFP
  • Educational Resource
    • Core Curricula
    • Teaching Software
  • Careers/Jobs
  • Council and Committees
  • Contact Us
  • Links
Ascept
Site Map

Ascept

Contact Ascept

Program

  • Home
  •  > 
  • Past Annual Scientific Meetings
  •  > 
  • 2010
  •  > 
  • Proceedings
  •  > 
  • Program

Workshops - Sunday 28 November

CAREERS WORKSHOP - 11am to 1pm
The workshop will feature successful scientists who have pursed careers that have involved a combination of “at the bench” and “beyond the bench” components. The workshop is designed to provide students and postdoctoral fellows with an insight into career options available to them beyond a traditional, laboratory-based research career. Panellists will discuss issues including the career path leading to their current role, day to day tasks, positive and negative aspects of the job, remuneration packages etc. There will also be plenty of opportunities for questions including a panel discussion at the end of the session.

Attendance at the workshop is included in a full registration fee. To assist in booking an appropriate size meeting room for the workshop please indicate your intention to attend when completing your online registration. Admission to the Careers Workshop is free and open to all registrants of the ASCEPT Annual Scientific Meeting. To assist in booking an appropriate size meeting room for the workshop please indicate you intention to attend when completing your online registration. For more information click here.

STATISTICS FOR CLINICIANS WORKSHOP - 10am to 12.30pm (morning tea included, an attendance charge applies). 
The language of clinical research is statistics. This workshop will introduce key concepts in statistics directed at critical appraisal. This workshop is put on by the Clinical SIG for all ASCEPT members. Members are encouraged to submit examples or questions for the panel discussion, these should be submitted as one (most 2) powerpoint slide to Matt.doogue@health.sa.gov.au.


Meeting Program

 

Sunday 28th November

1000 – 1100

Statistics for Clinicians Workshop CHAIR: Matt Doogue

1100 – 1300

Careers Workshop CHAIR: Barbara Kemp-Harper, Anna Davey

1000 – 1030

 

1030 – 1100

A question of confidence - David Vaux, La Trobe University

Is one of these just like the other one Evan Begg, University of Otago, NZ

1100 – 1125

 

 

 

1125 – 1150

 

 

1150 – 1215

 

1215 – 1240

 

 

1240 – 1300

A university teaching and research career: The best of both worlds? -Graham Mackay, University of Melbourne

Medical writing: What is it and is it right for me? - Rebecca Lew, ProScribe Medical Communications

Not tonight dear, I have a headache! -Sharyn Fitzgerald, ASPREE

A career in regulatory science - Janith Wickramaratna, NICNAS

 

Panel Discussion

1100 – 1120

Morning  Tea

 

 

1120 – 1150

 

 

1150 – 1230

 

Statistics for Clinicians Workshop cont.

You probably don’t know P - Michael Lew, University of Melbourne

 

Panel Discussion

1300 – 1400

Lunch

1300 – 1400 Pharmacogenomics SIG AGM - Room: Grand 3 

1300 – 1400

Toxicology SIG - Room: Grand 2

1400 – 1600

Exploiting Novel Drug Discovery Paradigms CHAIR: Arthur Christopoulos

1400 – 1600

Clinical Pharmacology Trainee Session CHAIR: Evan Begg

1400 – 1430

 

 

1430 – 1500

 

 

 

1500 – 1530

 

 

 

1530 – 1600

Differential signalling of opioid receptors - Mac Christie, University of Sydney, p215

From dyngoes to dynasores: Selective dynamin inhibitors as novel antiepileptic agents - Adam McCluskey, The University of Newcastle, p223

Exploiting nature’s diversity to discover allosteric drugs - Richard Lewis ,The University of Queensland, p214

Structure based drug design for complex GPCR targets; Studies on Relaxin Family Peptide Receptors - Ross Bathgate, University of Melbourne, p209

1400 – 1415

 

 

 

 

 

 

1415 – 1430

 

 

 

1430 – 1445

 

 

 

 

1445 – 1500

 

 

 

 

1500 – 1515

 

 

 

1515 – 1530

 

 

 

 

 

1530 – 1545

 

 

 

 

1545 - 1600

Prevention of Diabetes and Reduction in Major Cardiovascular Events in Studies of Subjects with Impaired Glucose Tolerance: Meta-Analysis of Randomized Controlled Clinical Trials - Ingrid Hopper, Alfred Hospital, p41

In vitro protein binding of lorazepam, oxazepam and temazepam with adult ageing - Paul Chin, Christchurch Hospital, p78
Variable pharmacokinetics of meropenem and piperacillin in patients with critical illness and renal failure - Darren Roberts, St Vincent's Hosptial, p96
Neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C in acute unwell general medical inpatients - Peter Donovan, Royal Brisbane and Women's Hospital, p160
Population pharmacokinetics of paracetamol in overdose in a single patient - Joel Iedema, Princess Alexandra Hospital, p85
Calcium channel blocker poisoning: evaluation of risk factors, predictors of severity and treatment of presentations to an inpatient toxicology centre - Trevor Mallard, Calvary Mater Newcastle, p168
Teaching Junior Medical Officers safe and effective prescribing - Robyn McCarthy, Royal North Shore Hospital, p30 

Open Discussion

1600 – 1630

Afternoon Tea

1630 – 1730

Plenary Lecturer - Julio Licinio, The John Curtin School of Medical Research CHAIR: John Miners

1730 – 1930

Poster  Presentations & Welcome Drinks

 
POSTER PRESENTATIONS

 

DRUG DISCOVERY

A behavioural study assessing spatial memory deficits in the APP/PS1 double transgenic mouse model of Alzheimer's disease using the Morris water maze – Stephen Edwards, The University of Queensland, p10
Alternative splicing of spca1 in breast cancer cell lines – Mariam Rizk, University of Queensland, p17
2’-methoxy-6-methylflavone: a novel allosteric activator of α4β1/2/3 GABAA receptors – Nasiara Karim, The University of Sydney, p23
3-oh-2’-methoxy-6-methylflavone: an allosteric modulator of synaptic while activator of extrasynaptic gabaa receptors - Nasiara Karim, The University of Sydney, p24.
Transcriptional Up-Regulation Of Human Udp Glucuronosyltransferase (Ugt) 2b15 And 2b17 By Dihydrotestosterone And Its Metabolites In Breast Cancer Mcf-7 Cells -
Dong Gui Hu, Flinders University, p29
IP3R-binding protein released with IP3 (irbit) in breast cancer cell lines – Aisyah Jahidin, The University of Queensland, p31
Investigate the species difference caffeine effect on TRPA1 ion channel – Liuqiong Gu, University of Melbourne, p38
Assessment of plasma membrane calcium atpase 1 sirna-mediated inhibition in MDA-MB-231 breast cancer cells – Merril Curry, The University of Queensland, p54
Stimulus-bias at the relaxin family peptide receptor 3 (RXFP3) – Martina Kocan, Monash University, p90
Autocrine annexin-1 activates formyl peptide receptors to increase breast tumour cell proliferation in response to serum, estradiol and epidermal growth factor
– Thippadey Khau, University of Melbourne, p93

 

 

 

Moonlighting enzymes: can kinases also contain guanylate cyclase activity? – Lubna Freihat, Monash, p98
Long-lasting effects of early-life stress on GABA-A receptors – Tina Hinton, The University of Sydney, p102
Predicting 5-HT1A receptor affinity of 1-adrenoceptor ligands – Timothy Nicholas, UNSW, p128
The role of PNU-120596, a selective positive allosteric modulator of the α7 nicotinic acetylcholine receptor in inflammation – Aileen Wu, University of Sydney, p134
Pathway-dependent allosteric modulation of the calcium sensing receptor – Anna Davey, Monash University, p136
The effects of abt-089 and analogues on stoichiometric combinations of RAT 4β2 nAChR - Taima Qudah, Sydney University, p151
Affinity and selectivity of diquinoline compounds at adrenoceptors and 5-HT1A receptor – Junli Chen, University of New South Wales, p152
Modulation of ligand binding to the 1b adrenoceptor: a potential role for the second extracellular loop – Adrian Campbell, University of New South Wales, p163
Structure-function studies of the human extracellular calcium-sensing receptor – Chongkai Wen, Monash Institute of Pharmaceutical Sciences, p178
Novel allosteric modultors and hybrid orthosteric/allosteric ligands of the adenosine a1 receptor – Emilia Savage, Monash University, p181
A putative modulator of the neurotrophin receptor P75NTR regulates peripheral myelination - Yong Zhou Lim, University of Melbourne, p185
Interaction with caveolin-1 modulates differential g protein coupling of mouse beta3-adrenoceptor isoforms – Bronwyn Evans, Monash Institute of Pharmaceutical Sciences, p186
Naringin and tertiapin-q share a binding site on girk channels – Elena Pera, University of Sydney, p11
Deglycosylation of the osmoreceptor trpv4 increases its basal activity  and permeability to the large cationic dye yo-pro 1 – Fe Abogadie, University of Melbourne, p52
Ethanol extracts of saw palmetto contain the indirectly acting sympathomimetic tyramine – Thiam Chua, Monash University, p64

Cysteine residues in the TRPV1 pore loop are critical determinants of channel calcium and Yo-Pro permeability – Marianna Volpert, University of Melbourne, p137
Revealing important roles for n-glycosylation in pore dilation and sustained elevation of intracellular calcium of the trpv1 receptor – Nik Veldhuis, University of Melbourne, p139
Valproate and the promiscuous delta-containing gabaa receptors – Divya Iyer, University of Sydney, p153
The serotonin 5-HT4 receptor splice variants interacts with specific PDZ domain proteins veli 1-3/LIN7A, B, C homologues: mechanisms in receptor targeting – Kenneth Chinkwo, Monash University, p169
Mutations in TRPV4 cause an inherited arthropathy of hands and feet – Yuan Yuan, University of Melbourne, p172
Wound healing efficacy of seabuckthorn leaf aqueous extract in diabetic rats – Nitin Kumar Upadhyay, University of Delhi, p174
Drug transporters in human mammary epithelial cells - Lisa B.G. Tee, Curtin University, p195
Investigating the role of the low density lipoprotein class A (LDLA) module in mediating activation of the relaxin family peptide receptor (RXFP) 1 and RXFP2 - Roy Chze Khai Kong, Howard Florey Institute, p75
Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue – Virginia Ip, University of Auckland, p88
Growth factor-mediated changes in purinergic receptor signaling in breast cancer cells – Felicity Davis, The University of Queensland, p9 

DRUG DISPOSITION

 

Hepatic Drug Disposition in Liver Disease: Liver histopathology and hepatic drug transporter activity as determinants of drug disposition in liver diseases – Peng Li, The University of Queensland, p7

 

 

 

UDP-glucuronosyltransferase 2B7 (UGT2B7) Utilises Both UDP-Glucuronic Acid and UDP-Glucose as Co-factors in the Metabolism of Morphine – Nuy Chau, Flinders University, p94
Computational modeling and structure-activity relationships of cytochrome P450 1A1: enhanced activation of the chemotherapeutic prodrug dacarbazine – Benjamin Lewis, Flinders University, p188
Comparison of drug binding to human serum albumin and liver fatty acid binding protein; potential implications for intra and inter cellular hepatic transport – Andrew Rowland, Flinders University, p37
Prediction of paclitaxel clearance from in vitro kinetic data – Tahlia Heath, University of South Australia, p21 


GASTRO-UROGENITAL

Spontaneous activity in isolated bladder strips from the streptozotocin-induced diabetic rat: effct of cholinergic modulation and the mucosa – Donna Sellers, Bond University, p12
Investigating the atheroprotective effect of testosterone: role in modulation of inflammatory markers in the development of early atherogenesis in the testicular feminised mouse model – Donna Sellers, Bond University, p13
The effect of ovariectomy and dietary phytoestrogen on relaxant responses to adenosine receptor analogues in the rat isolated bladder – Roselyn Rose'Meyer, Griffith University, p39
NKA modulation of urothelial and detrusor responses to ATP and carbachol – Natasha Hausman, Bond University, p87
Relaxant effects of methanandamide unmasked by indomethacin in the mouse uterus – Karen Kerr, University of Newcastle, p104
Characterisation of the muscarinic receptor subtype regulating urothelial spontaneous contractile activity – Christian Moro, Bond University, p105
Short term cafeteria diet increases serotonin availability in the rat ileum – Rebecca Bertrand, University of New South Wales, p108
The influence of the mucosa on contractile responses of the internal anal sphincter (IAS) – Russ Chess-Williams, Bond University, p127
Amiloride reduces 5-HT release from EC cells of guinea pig intestine – Kate Polglaze, University of New South Wales, p131
Age related changes in the contractile response of the mouse prostate gland – Carl White, Monash Institute of Pharmaceutical Science, Monash University, p135
Differential expression of oestrogen and progesterone receptors in the colon of females with slow transit constipation – Lu Liu, University of New South Wales, p142

Characterisation of inflammatory phenotype in human colitis explant model – Benjamin Harvey, The University of Adelaide, p148
Identifying novel urinary biomarkers – towards a new therapeutic target in overactive bladder (OAB) disease – Orla Teahan, UNSW, p149

INFLAMMATION/RESPIRATORY

Serum-induced chemo- attractant and kinetic responses of MDA-MB-231 breast tumour cells are prevented by dexamethasone, but uninfluenced by formyl peptide receptor (FPR) ligands – Ebony Fietz, University of Melbourne, p22
Morphine- and LPS-induced cellular proinflammatory cytokine production in mice: comparison of three mouse strains – Liang Liu, University of Adelaide, p42
Suppression of inflammation by opioids and bisphosphonates in arthritis - Jignya H Patel, University of New South Wales, p50
Deletion of the interferon a receptor1 (IFNAR1) subunit of the type I interferon receptor confers protection to neuronal tissue following traumatic brain injury – Ila Karve, University of Melbourne, p58

Expression and function of FcγRIIa in mast cells and the lung: a role in asthma? – Patrick Heng, University of Melbourne, p68
Function and expression of novel MS4A members in atopic asthma - Li Eon Kuek, University of Melbourne, p69
Glutathione peroxidase-1 (GPX-1) reduces influenza a virus-induced lung inflammation – Selcuk Yatmaz, The University of Melbourne, p91
Implications of interferon dependant activation of JAK-STAT pathway in neuro-inflammation – Myles Minter, University of Melbourne, p115

3, 4-methylenedioxymethamphetamine (MDMA) – induced hyperthermia is attenuated by administration of interleukin-1 (IL-1) receptor antagonist (IL-1RA) in rats – Jake Gordon, University of Adelaide, p124
Recombinant granulocyte/macrophage colony-stimulating factor (GM-CSF) fails to restore macrophage function, and surfactant proteins (SP) suppress host defences, in pulmonary alveolar proteinosis (PAP) – Matt Radojcic, University of Melbourne, p132
Transforming growth factor β (TGFβ) induces glucocorticoid-resistance in human airway epithelia by reducing glucocorticoid receptor nuclear localisation – Saad Salem, The Univesity of Melbourne, p146
Influence of influenza infection on sensory nerve function in mouse airways – Samuel Taylor, University of Western Australia,p62
IL-4, IL-13 and TNF TNFα Inhibit GRE activation and synergise to down-regulate GRα levels in human bronchial epithelial cells – Christine Keenan, University of Melbourne, p121
Airway reactivity to both constrictors and dilators is altered in vitro in a sheep model of chronic allergic airways disease – James Esposito, University of Melbourne, p125

Monday 29th November

0820 – 0830

Official Welcome - Professor Kathie Knights, Immediate Past President, ASCEPT

0830 – 0930

ASCEPT Plenary Lecturer - Professor Felix Bochner, p212 CHAIR: Kathie Kights

0930 – 1030

Plenary Speaker - British Pharmacological Society

Professor Simon Maxwell, Clinical Pharmacology, University of Edinburgh, Scotland, Abstract CHAIR: Kathie Kights

1030 – 1100

Morning  Tea & Poster Presentations

 
POSTER PRESENTATIONS

 

CARDIOVASCULAR

Hydrogen sulphide relaxes middle cerebral arteries in rats – Eloise Streeter, RMIT University, p14

Endothelial protective effects of boldine in streptozotocin-induced diabetic rat: free radical scavenging activities and inhibition of protein kinase C –

Yeh Siang Lau, University of Malaya, p34
Effect of carpobrotus rossii (‘pigface”) ingestion on blood pressure, body and organ weight, blood lipids, haematological profile and in vitro vascular responses in rats – Dominic Geraghty, University of Tasmania, p36
Resistin can act in the brain to influence cardiovascular regulation – Samin Kosari, RMIT University, p61
TRPC3 channels facilitate KCA-mediated endothelial signaling in rat mesenteric artery – Sevvandi Senadheera, University of New South Wales, p72
Are the cardiac effects of nitroxyl (HNO) preserved in a high glucose setting in neonatal rat cardiomyocytes (NRCM)? – Shreeleka Rao, University of Melbourne, p92
Effects of omega-3 fatty acids and proinflammatory mediators on superoxide generation and nitric oxide synthase (eNOS) expression in quiescent human umbilical vein endothelial cells (HUVECs) – Karina Hamilton, University of the Sunshine Coast, p110
Nitroxyl (HNO) suppresses superoxide generation by nadph-oxidase in the cerebral vasculature – Kate Maxwell, Monash University, p112
Effects of omega-3 fatty acid supplementation on Weibel-Palade body degranulation in human endothelial cells – Corinna Burgin, University of the Sunshine Coast, p122
A reduced capacity to exercise is associated with cardiac remodelling in rats – Marissa Bowden,  Baker IDI Heart and Diabetes Institute, p133
Endothelial cationic amino acid transporter 1 (CAT-1) overexpression protects against diabetes-induced cardiac dysfunction in mice – Makhala Khammy, The University of Melbourne, p140
The effects of serum, ischemia and adenosine receptor activation on erk phosphorylation in a cardiac cell line model – Ruchi Kanojia, Monash University, p157
Contribution of transmembrane domain V amino acids to β1L-adrenoceptor activity and affinity – Paul Klenowski, Queensland University of Technology, p170
Macrophages in the vascular wall of hypertensive mice are ‘alternatively’ activated and derived from circulating LY6CHI monocytes – Jeffrey Moore, Monash University, p182
Zoledronic acid increases eNOS expression and improves endothelial function – Oguzhan Yildiz, Gulhane School of Medicine, Ankara, Turkey, p3
Heart rate variability more sensitive than cortisol to exam stress in students – Sara Vafaeiafraz, The University of Sydney, p20
Diet-induced obesity alters vasodilator mechanisms in the rat middle-cerebral artery – Lauren Howitt, UNSW, p86
The sphingosine 1-phosphate mimetic, FTY720, suppresses superoxide generation and elicits nitric oxide-dependent dilatation in the cerebral circulation – Jacqueline Ku, Monash University, p99
Effect of glycated human serum albumin on BKCa-mediated responses in rat and human small arteries - Matthew           Rikard-Bell, UNSW, p120
Correction of abnormal fenestrations in the diabetic liver with 3,3’,5,5’-tetra-t-butyl-biphenyl-4,4’-diol, a novel antioxidant compound – Aisling McMahon, ANZAC Research Institute, p162
Do connexins 37, 40 and 43 play a role in endothelial dysfunction in cremaster arteries from type-2 diabetic rats? – Marshan Youssef, RMIT University, p180
Olfactory receptor systems in the heart – Simon Foster, University of Queensland,p197
Vasorelaxant and anti-aggregatory actions of nitroxyl (HNO) are preserved, yet those to nitric oxide (NO) compromised, in hypercholesterolemic mice – Michelle Bullen, Monash University, p116 
MyD88-dependent signaling following stroke – Catherine Downes, Melbourne University, p126

CLINICAL

The effect of allopurinol on thiopurine metabolite concentrations in patients with inflammatory bowel disease – Tegan Asser, University of South Australia, p28
Local anaesthetic infused at the incision site for post-operative pain management following abdominal surgery – Ray Morris, The Queen Elizabeth Hospital, p33
Drug burden index (DBI) associated with function in older people living in Finland – Danijela Gnjidic, University of Sydney and Royal North Shore Hospital, p45
Development of a population pharmacokinetic (POPPK) model to describe the variability in metformin pharmacokinetics – Shaun Kumar, St Vincent's Hospital, p55
Optimising the management of gout with allopurinol – Diluk Kannangara, St Vincent's Hospital, p57
Multimodal CNS pharmacodynamics with the neurocart using lorazepam as a probe drug – Nur Yasmin Ayub, University of Adelaide, p73
A comparison of suspected paracetamol toxicity in young and old patients at a Sydney hospital over 18 months – Alice Kane, University of Sydney/Royal North Shore Hospital, p101
Presentation of sepsis and gentamicin dosing in young and old hospital inpatients – Claire Johnston, University of Sydney/Royal North Shore Hospital, p109
The impact of frailty on gentamicin pharmacokinetics in septic older inpatients – Claire Johnston, University of Sydney/Royal North Shore Hospital, p113
Development of an LC-MS/MS method suitable for tacrolimus quantification in tissue – Benjamin Noll, The Queen Elizabeth Hospital, p144
Intra-renal cyclosporine concentrations in kidney transplant recipients experiencing rejection or other graft dysfunction – Benedetta Sallustio, The Queen Elizabeth Hospital, p158
The acute effects of naltrexone on the psychomotor effect of alcohol in healthy volunteers – Nur Yasmin Ayub, University of Adelaide, p171
Comparison of one vs two blood samples for determination of tobramycin AUC in children with cystic fibrosis – Ross Norris, Mater Health Services, p190
Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients – Michael Lobb, Mater Health Services, p196
Short-term exposure of patients with chronic renal impairment to metformin – Janna Duong, University of New South Wales, p8
Drug burden index (DBI) and mortality in Australian veteran population – Danijela Gnjidic, University of Sydney and Royal North Shore Hospital, p117
Assessment of cytochrome P450 inactivation efficacy as a predictor of pharmacokinetic drug-drug interactions – Kyra Barnes, Flinders University, p25
The assay of melatonin in saliva by high-performance liquid chromatography-tandem mass spectrometry – Sohil Khan, The University of Queensland, p194
Pulmonary fibroblasts from patients with COPD have a senescent secretory phenotype – Lian Wu, University of Auckland, p211
Drug burden index (DBI) and beers criteria: impact on function in older people living in self-care retirement villages – Danijela Gnjidic, University of Sydney and Royal North Shore Hospital, p47
Opioid analgesia, tolerance and withdrawal: contributions of innate immune signalling and sex – Mark Hutchinson, University of Adelaide, p60
Patients’ perceptions of generic medications - Suong N T Ngo, The University of Adelaide, p166

 

 

 

 

 

 

 

PHARMACOGENOMICS

Mechanistic contribution of toll-like receptors and microglia towards alcohol effects and alcohol-opioid interactions – Yue Wu, University of Adelaide, p18
Counter regulation of morphine and oxycodone analgesia: a TLR4 map kinase mediated phenomenon? – Jacob Thomas, University of Adelaide, p56
Identification of transcription factors regulating UDP-glycosyltransferase 3A1 and 3A2 gene expression – Alex Haines, Flinders University, p95
Microarray analysis of global gene expression as a tool to identify potential drug targets for the treatment of werner syndrome. Studies in a mouse model – Dmitri Svistounov, ANZAC Research Institute,p193

TOXICOLOGY

Transcriptome profiling of acute acrolein pneumotoxicity in mice – Philip Burcham, University of Western Australia, p46
Illicit stimulant use in adelaide monitored by wastewater analysis – Chang Chen, University of Adelaide, p51
Effect of paracetamol toxicity on kupffer cell numbers in perfused livers of young male fischer 344 rats – Alice Kane, University of Sydney/Royal North Shore Hospital,p103
The impact of poloxamer 407 (P407) on the ultrastructure of the liver and evidence for clearance by extensive endothelial and kupffer cell endocytosis – Alessandra Warren, University of Sydney, p192
The expression of NRF2 and CYP2E1 in paracetamol induced hepatoxicity of fisher 344 rats – John Mach, Royal North Shore Hospital, p164
Cytotoxic and apoptosis induction of Malaysian marine endophytic fungi – Siti Alwani Ariffin, Otago University of Wellington, p165
Prior acute acrolein exposure accelerates the onset of pulmonary inflammation in influenza a infected mice – Ferrer Ong, University of Western Australia, p187 
Solving the ‘brown snake paradox’: an in vitro comparison of the activity of snake presynaptic neurotoxins – Carmel Barber, Monash University, p71


EDUCATION

Is non-attendance at lectures indicative of lack of engagement of students with their studies? – Elizabeth Davis, Monash University, p19
Ensuring quality graduates of pharmacology: a survey of Australian students – Lynette Fernandes, University of Western Australia, p129
e-Pharmacology: An on-line resource for medical students – Eva Patak, Monash University, p141
Ensuring quality graduates of pharmacology: an Australian survey of pharmacology teaching – Tina Hinton, The University of Sydney, p143
Assessing student preconceptions and misconceptions of therapeutic pharmacology topics as an engagement and teaching strategy – Joanne Hart, RMIT University, p179

GASTRO-UROGENITAL
Physiological concentrations of iron alter the motility of the guinea pig jejunum – Kej Wang, University of New South Wales, p130 

1100 – 1300

Current Challenges Facing Pharmacogenomics CHAIR: Janet Coller, Andrew Somogyi

1100 – 1300

Immunopharmacology in Diseases of the Cardiovascular, Respiratory & Central Nervous System CHAIR: Grant Drummond

1100 – 1120

 

 

1120 – 1140

 

 

1140 – 1200

 

 

 

 

1200 – 1220

 

 

 

 

1220 – 1300

Role of epigenetics and miRNAs - Ross McKinnon, University of South Australia, p218

Next gen sequencing analysis challenges - David Adelson, University of Adelaide, p220

Translation of pharmacogenetic testing into clinical practice- National and international perspectives - Andrew Somogyi, University of Adelaide, p203

The pharmas and the cowboys should be friends - Jennifer Martin & John Duley, University of Queensland, p198

 

Panel Discussion

1100 – 1130

 

 

1130 – 1200

 

 

 

1200 – 1220

 

 

 

1220 – 1240

 

 

 

1240 – 1300

 

 

The role of T-cells and the adpative immune response in hypertension - David Harrison, Emory University, USA

Targeting chemoattractant receptors for anti-inflammatory therapy  - Charles Mackay, Monash University, p200

Inflammation and immune mechanisms of brain damage after stroke - Chris Sobey, Monash University, p204

Chemokine receptor antagonism in the treatment of autoimmune disease of the CNS - Iain Comerford, University of Adelaide, p210

Novel pharmacological strategies for the treatment of COPD - Ross Vlahos, University of Melbourne, p202

1300 – 1400

Lunch & Poster Presentations - TBA

1300 – 1400

Pharmacology SIG - Room: Grand 3

1400 – 1600

Oral Presentations 1 CHAIR: Matt Doogue

1400 - 1600

Oral Presentations 2 CHAIR: Greg Monteith

1400 – 1415

 

 

 

1415 – 1430

 

 

 

 

 

1430 – 1445

 

 

1445 – 1500

 

 

 

 

 

 

1500 – 1515

 

 

 

1515 – 1530

 

 

 

 

 

 

1530 – 1545

 

 

 

 

1545 – 1600

BICEPP: a computational text mining method for predicting binary characteristics of drugs - Frank Lin, University of New South Wales, p40

Estimation of lean body weight in older black and white men and women: the health, aging and body composition study - Sarah Mitchell, Royal North Shore Hospital and The Univeristy of Sydney, p207
Total and free clearance of R- and S-warfarin in elderly people - Berit P. Jensen, University of Otago,p76
The PD and PK of single dose R-warfarin and S-warfarin when administered alone and in combination as a function of VKORC1 genotype in healthy volunteers - John Maddison, Royal Adelaide Hospital, p159
Short-term exposure of patients with chronic renal impairment to metformin - Janna Doung, University of New South Wales, p8
Effects of changing from oral to subcutaneous administration of methotrexate on RBC MTX polyglutamate concentrations and disease activity in patients with rheumatoid arthritis - Murray Barclay, Christchurch Hospital, p79
Plasma oxypurinol concentrations in patients with allopurinol-induced stevens johnson syndrome—case series - Hugo Lee, St Vincent's Hospital, p49
Assessing the adverse effects caused by oral anticancer drug capecitabine - Hamed Shahnam, Flinders Medical Centre,p70

1400 – 1415

 

 

 

 

1415 – 1430

 

 

 

 

 

1430 – 1445

 

 

 

 

1445 – 1500

 

 

  

 

1500 – 1515

 

 

 

1515 – 1530

 

 

 

 

1530 – 1545

 

 

 

1545 – 1600

Basic fibroblast growth factor inhibits airway small muscle cell acquisition of a myofibroblast phenotype - Alastair Stewart, University of Melbourne, p114

Absence of development of learned helplessness and C-FOS expression in P2X7 receptor knockout mice when repeatedly tested in the forced swim test - Aurelie Boucher, University of Sydney, p63
Transient receptor potential vanilloid 1 (TRPV1) in naïve and THP-1 monocytes: role in cytokine release - Dale Kunde, University of Tasmania, p111
Autocrine annexin-1 activates formyl peptide receptors to increase breast tumour cell proliferation in response to serum, estradiol and epidermal growth factor - Thippadey Khau, University of Melbourne, p93
An animal model of gene-environment interactions in schizophrenia - Jonathon Arnold, University of Sydney, p100
A non-peptidic oxytocin receptor agonist as a novel therapeutic lead for the treatment of anxiety - William Jorgensen, The University of Sydney, p80
Investigating the role of binding site cooperativity in mediating functional effects at the translocator protein - Alana Scarf, University of Sydney, p65
A versatile microglia-neuron co-culture system for the identification of anti-inflammatory and neuroprotective drugs - application to screening of natural compounds - Gerald Muench, UWS,p167

1600 – 1630

Afternoon Tea & Poster Presentations

1630 – 1830

Denis Wade J & J Plenary Session CHAIR: Barbara Kemp-Harper

1630 – 1700

 

1700 – 1730

 

1730 – 1800

 

 

1830 – 1830

The development of atherosclerosis and hypertension: the role of vascular arginase – Karen Andrews, Baker IDI Heart and Diabetes Institute,p155

A pre-assembled G-protein-coupled receptor signalosome with sensitivity to sub-picomolar concentrations of relaxin – Michelle Halls, University of Cambridge, p74
Characterisation of a novel neuropeptide/GPCR system in brain: relaxin-3/RXFP3 signalling modulates septohippocampal theta rhythm and spatial memory – Sherie Ma, Florey Neurosciences Institute and Austin Health, p217
Characterisation of dorsal root ganglion neuron populations activated by ciguatoxin – Irina Vetter, University of Queensland, p123

1830 – 1930 Drug Discovery SIG – Room: Grand 2

Tuesday 30th November

0830 – 1030

So Much to Teach… So Little Time CHAIR: Elizabeth Davis

0830 – 1030

Antivenom Treatment: Efficacy Versus Effectiveness, the New and Improving the Old CHAIR: Geoff Isbister

0830 – 0850

 

 

0850 – 0910

 

0910 – 0930

 

 

 

 

0930 – 1000

 

 

 

 

 


 

 

 

1000 – 1030

And what were the best aspects of your course? - Ieva Stupans, University of New England, p222

Feedback on student performance - Emilio Badoer, RMIT University, p201

Bringing practice to practicals: Placing and assessing undergraduate students on primary research - Jeff Schwartz, Griffith University, p191

Debate: So much to teach/learn… So little time… So no time for pracs - Julianne Reid, RMIT University, Michael Lew, University of Melbourne, Dominic Geraghty, University of Tasmania, Enis Kocak, Monash University, Benjamin Harvey, University of Adelaide, Brad Watmuff, Monash University

 

Panel Discussion

0830 – 0855

 

 

 

0855 – 0920

 

 

 

0920 – 0945

 

 

 
 

0945 – 1010

 

 

 

1010 – 1030

New approaches to improve and old therapy - Snake antivenom - Robert Harrison, Liverpool School of Tropical Medicine, UK, p216

Investigating the efficacy of antivenom therapy with in vitro and animal studies - Wayne Hodgson, Monash University, p206

Using mechanistic models and simulations to understand snake bite coagulopathy and the effectiveness of antivenom - Stephen Duffull, University of Otago, p213

Developing a rational approach to antivenom therapy - Geoff Isbister, Newcastle Mater Hospital, p221

 

Panel Discussion

1030 – 1100

Morning  Tea

1030 – 1100

Cardiovascular SIG – Room: Grand 5/6

1100 – 1300

Oral Presentations 3 CHAIR: Alyson Miller

1100 – 1300

Oral Presentations 4 CHAIR: Carl Kirkpatrick, Ian Musgrave

1100 – 1115

 

 

 

 

1115 – 1530

 

 

 

 

 

1130 – 1145

 

 

 

 

 

1145 – 1200

 

 

 

 

 

 

1200 – 1215

 

 

 

 

1215 – 1230

 

 

 

1230 – 1245

 

  

 

1245 – 1300

Hypoxic preconditioning enhances survival of human adipose-derived stem cells for tissue engineering - Samantha Stubbs, The University of Melbourne, p154
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate - Suree Lekawanvijit, Monash University,p173
Generation of a novel antagonist of the human protease-activated receptor-4 uncovers a role for this receptor in the platelet procoagulant response - Justin Hamilton, Monash University,p48
Excessive superoxide production and endothelial dysfunction in cerebral arteries following transient cerebral ischaemia are due to enhanced activity of NOX2-containing nadph-oxidase - Alyson Miller, Monash University,p97
Hydrogen sulfide elicits vasoprotection by scavenging superoxide anions and inhibiting vascular NADPH oxidase - Joanne Hart, RMIT University, p84
Effect of a CXCR2 antagonist on brain inflammation and infarct volume after stroke in mice - Vanessa Brait, Monash University, p59
G protein-coupled estrogen receptor signalling in the brain worsens stroke outcome in males but protects in females - Brad Broughton, Monash University, p147
Anti-inflammatory peptide annexin-a1 (ANX-A1) postconditions cardiac function in the intact rodent heart subjected to ischaemia-reperfusion (I-R) injury
- Rebecca Ritchie, Baker IDI Heart & Diabetes Institute, p145

1100 – 1115

 

 

 

 

 

 

 

1115 – 1530

 

 

 

1130 – 1145

 

 

 

1145 – 1200

 

 

 

1200 – 1215



1215 – 1230




1230 – 1245


1245 – 1300

Comparison of predicted dose versus actual dose using three different pharmacogenomic algorithms in a case-control study of 483 patients on long

term warfarin therapy - Leslie Sheffield, Murdoch Childrens Research Institute, p184
Relationship between immunogenetics and risk of drug dependence - Janet Coller, University of Adelaide,p43
TPMT genotyping results from a clinical pharmacogenetics service to assist azathioprine dosage initiation: the first 500 patients - Andrew Somogyi, University of Adelaide, p161
Structure toxicity studies of drugs implicated in immune-mediated idiosyncratic hepatotoxicity - Samuel Ho, The University of Sydney, p53
Human health risk assessment of dioxin contamination in a pesticide - Edward Cram, Department of Health and Ageing, p183
The effects of chironex fleckeri crude venom extract on isolated cardiac and vascular tissues - Richard Hughes, The University of Melbourne, p138
Optimising Gentamicin use in a tertiary hospital setting - Jennifer Martin, UQ, p177
Outcomes in patients with gram negative sepsis treated with gentamicin
- Peter Pillans, Princess Alexandra Hospital, p83

1300 – 1400

Lunch & Poster Presentations

1300 – 1400

Gastro-Urogenital SIG – Room: Grand 3

1300 – 1400

Education SIG – Room: Grand 2

1400 – 1600

ASCEPT Oral Session CHAIR: Barb Kemp Harper

 1400 – 1415

 

 

1415 – 1430

 

1430 – 1445

1445 – 1500

 

1500 – 1515

 

1515 – 1530

 

 

1530 – 1545

 

1545 – 1600

Vasorelaxant and anti-aggregatory actions of nitroxyl (HNO) are preserved, yet those to nitric oxide (NO.) compromised, in hypercholesterolemic mice - Michelle Bullen, Monash University, p116
Growth factor-mediated changes in purinergic receptor signaling in breast cancer cells - Felicity Davis, The University of Queensland, p9
MyD88-dependent signalling following stroke - Catherine Downes, Melbourne University, p126
Drug Burden Index (DBI) and mortality in Australian Veteran Population - Danijela Gnjidic, University of Sydney and Royal North Shore Hospital, p117
Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue - Virgina Ip, University of Auckland, p88
Investigating the role of the low density lipoprotein class A (LDLA) module in mediating activation of the relaxin family receptor (RXFP) 1 and RXFP2 - Roy Chze Khai Kong, Howard Florey Institute, p75
Age-related loss of fenestrations impairs hepatic uptake of the water soluble substrate paracetamol - Sarah Mitchell, Royal North Shore Hospital and University of Sydney, p15
CYP1A2 activity in south asians and Europeans - Vidya Perera, The University of Sydney, p32

1600 – 1630

Afternoon Tea

1630 – 1830

ASCEPT Annual General Meeting - Agenda
Cardiovascular SIG Report
Drug Discovery SIG Report
Education SIG Report
Pharmacogenomics SIG Report
Clinical SIG Report
Toxicology SIG Report

1930

Conference Dinner, Sebel Ballroom

Wednesday 1st December

0830 – 1030

Medication Safety: Innovations CHAIR: Ric Day, Johanna Westbrook

0830 – 1030

Oral Presentations 5 CHAIR: Tom Polasek, Betty Exintaris

0830 – 0855

 

0855 – 0915

 

  

0915 – 0935

  


0935 – 0955

 

 

 

0955 – 1015

 

 



1015 – 1030

As you like it - Mukesh Haikerwal, National E-Health Transition Authority
Mindlines: Sources of medication errors - William Runciman, University of South Australia, p219
Trials and tribulations of implementing electronic medication management systems
- Ric Day, University of New South Wales, p224

The impact of electronic medication management systems on prescribing errors in hospitals - Johanna Westbrook, The University of Sydney, p189
The impact of computerised decision support on selecting medicines for prescription
- Melissa Baysari, University of New South Wales, p205


Panel Discussion

0830 – 0845

 

 

 

 

0845 – 0900

 

 

 

 

 

0900 – 0915

 

 

 

 

 

0915 – 0930

 

 

 

0930 – 0945

 

 

0945 – 1000

 

 

1000 – 1015

 

 

 

 

 

1015 – 1030

Protein kinase C regulates the internalization and function of the human organic anion tranpsoring polypeptide - Fanfan Zhou, The University of Sydney, p2
Inhibition of proliferation and migration of COX-2-overexpressing breast cancer cells by synthetic omega-3 monounsaturated fatty acids - Pei Cui, University of Sydney, p44
Dimeric complexes containing the leucine zipper factors c-JUN and MafG activate transcription of the human CYP2J2 epoxygenase gene - Michael Murray, University of Sydney, p81
Prediction of paclitaxel clearance from in vitro kinetic data - Tahlia Heath, University of South Australia, p21
Neurotransmitters regulating tone of the internal anal sphincter  - Natasha Hausman, Bond University, p89
Adrenoceptor subtypes regulating urothelial spontaneous contraction - Christian Moro, Bond University, p107
Investigation of receptors and mediator release in the porcine bladder mucosa – a role for tachykinins and other endogenous agonists? - Elizabeth Burcher, University of New South Wales, p150
Acid and acid-sensitive receptors in the porcine urinary bladder - Felicity Kao, University of New South Wales, p156

1030 – 1100

Morning  Tea

1100 – 1200

Plenary Speaker - British Toxicology Society

Prof Timothy Gant, Medical Research Council Toxicology Unit and Reader in Genetics, University of Leicester, UK, Abstract CHAIR: David Le Couteur

1200 – 1230

Prize Giving and Conference Close CHAIR: David Le Couteur

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ascept